regulatory
confidence high
sentiment positive
materiality 0.60
GridAI Technologies Corp. (GRDX): Nasdaq/NYSE listing notice — Nasdaq issues reprimand to First Wave BioPharma for shareholder approval lapse; matter closed
GridAI Technologies Corp.
- On March 19, 2024, Nasdaq issued a Letter of Reprimand for the July 2023 offering of 610k shares and warrants at $0.64/share.
- The offering was deemed not a public offering under Rule 5635(d) because one investor bought a predominant portion; shareholder approval was required but not obtained.
- The Company obtained shareholder ratification on December 12, 2023, as remedial action.
- Nasdaq noted the failure was inadvertent, no prior pattern of non-compliance, and considers the matter closed.
- No delisting or further sanctions imposed; the Company remains listed on Nasdaq.